DeRoyal Covaderm Plus Vascular Access Dressing Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
DeRoyal Industries Inc. is recalling 800 units of Covaderm Plus Vascular Access Dressing due to lack of sterility assurance.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on July 10, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
DeRoyal Industries Inc. initiated a voluntary recall of sterile wound dressings because the products lack sterility assurance.
Which Products Are Affected
The recall involves DeRoyal Industries Inc. Ref 46-406, Covaderm Plus, Vascular Access Dressing 6"x6" (15cmx15cm). A total of 800 units are affected, distributed nationwide in the states of FL & NC. The affected lot is 63295141. The recall number is Z-2305-2026.
What You Should Do
Consumers should follow guidance from the recalling firm or FDA regarding the affected products.
Why This Matters
The recalled dressings are intended for vascular access sites and the lack of sterility assurance may pose an infection risk.
Source
FDA Recall Z-2305-2026 - DeRoyal Industries Inc., Powell, TN
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (800 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to July 10, 2026.
Frequently Asked Questions
Common questions about this FDA recall.